| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.68B | +7.4% |
| Cost of Revenue | $876.5M | +6.3% |
| R&D Expense | $36.8M | -14.6% |
| SG&A Expense | $391.8M | +2.7% |
| Operating Income | $1.13B | -19.5% |
| Interest Expense | $115.5M | -16.8% |
| Pre-tax Income | $1.03B | -18.6% |
| Income Tax | $258.8M | +17.5% |
| Net Income | $614.6M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $302.7M | +169.1% |
| Accounts Receivable | $334.2M | +15.2% |
| Current Assets | $810.1M | -12.4% |
| Total Assets | $4.37B | -37.3% |
| Current Liabilities | $771.4M | -66.7% |
| Long-term Debt | $2.88B | -23.0% |
| Total Liabilities | $4.04B | -22.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.06B | +0.2% |
| Capital Expenditures | $230.0M | -16.3% |
| Investing Cash Flow | $2.75B | +811.2% |
| Financing Cash Flow | -$3.79B | -184.7% |
| Free Cash Flow | $830.7M | +5.9% |
| -35.6% |
| EPS (Basic) | $4.19 | -30.6% |
| EPS (Diluted) | $4.17 | -30.5% |
| Stockholders' Equity |
| $310.0M |
| -82.3% |